중동과 아프리카 안과 시장 보고서 - 산업 동향 및 2032년까지의 예측

Middle East And Africa Ophthalmology Market

시장 규모 (USD 10억)

연평균 성장률 : 4.50 %

USD 3.12 Billion USD 4.42 Billion 2024 2032

예측 기간	2025 –2032
시장 규모(기준 연도)	USD 3.12 Billion
시장 규모(예측 연도)	USD 4.42 Billion
연평균 성장률	4.50 %
주요 시장 플레이어	Dummy1 Dummy2 Dummy3 Dummy4 Dummy5 잠금 해제 요청

Middle East and Africa Ophthalmology Market Segmentation, By Products (Device, Drugs, and Others), Diseases (Cataract, Refractive Disorders, Glaucoma, Age-Related Macular Degeneration, Inflammatory Diseases, and Others), Comprehensive Eye Examination (Refraction, Visual Acuity Test, Intraocular Pressure, Anterior Segment and Pupillary Examination, Visual Fields Test, Color Vision Test, and Others), End User (Clinics, Hospitals, Home Healthcare, and Others), Distribution Channel (Retail Sales, Direct Tender, and Others) - Industry Trends and Forecast to 2032

Middle East and Africa Ophthalmology Market Analysis

The Middle East and Africa ophthalmology market has evolved significantly over the centuries, beginning with ancient treatments for eye conditions in Egypt and Greece. The field began to take shape in the 17th and 18th centuries, with the development of more advanced surgical techniques and tools. In the 19th century, innovations like the ophthalmoscope transformed diagnostic capabilities. The 20th century saw breakthroughs such as cataract surgery and the invention of intraocular lenses, along with the advent of LASIK surgery in the 1990s. The 21st century brought continued growth driven by an aging population, technological advancements, and the development of specialized diagnostic and surgical devices, including optical coherence tomography (OCT) and retinal imaging systems. Recent trends focus on the increasing use of artificial intelligence, telemedicine, and biologic therapies, such as gene therapy and stem cell treatments, further shaping the market's growth. Today, the ophthalmology market continues to expand due to rising eye disease prevalence, new technologies, and evolving treatment options.

Middle East and Africa Ophthalmology Market Size

The Middle East and Africa ophthalmology market is expected to reach USD 4.42 billion by 2032 from USD 3.12 billion in 2024, growing at a CAGR of 4.5% in the forecast period of 2025 to 2032.

In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include import export analysis, production capacity overview, production consumption analysis, price trend analysis, climate change scenario, supply chain analysis, value chain analysis, raw material/consumables overview, vendor selection criteria, PESTLE Analysis, Porter Analysis, and regulatory framework.

Middle East and Africa Ophthalmology Market Trends

“Enhanced Safety and Efficiency of Saline Prefilled Syringes”

The Middle East and Africa ophthalmology market is experiencing robust growth, driven by the rising prevalence of eye diseases, technological advancements, and an aging population. Increasing rates of conditions such as cataracts, glaucoma, diabetic retinopathy, and age-related macular degeneration are contributing to the rising demand for eye care treatments. The aging Middle East and Africa population is particularly impacting this trend, as older individuals are more prone to vision-related issues. Additionally, advancements in diagnostic technologies, such as optical coherence tomography (OCT), fundus cameras, and AI-powered systems, are improving the accuracy and efficiency of diagnoses. Minimally invasive surgical techniques, including laser treatments and robotic-assisted surgeries, are gaining popularity, offering faster recovery times and improved patient outcomes. Furthermore, the growth of personalized medicine in ophthalmology, with targeted therapies for conditions like retinal diseases, is also playing a pivotal role. The introduction of novel drug delivery systems, such as injectable biologics and sustained-release implants, is improving treatment efficacy, particularly for chronic conditions. Telemedicine is another growing trend in the ophthalmology market, as remote consultations and virtual screenings become more common, enhancing access to care in underserved regions. Key market players are focusing on research and development to expand their product portfolios, while emerging markets are seeing an increased demand for affordable, accessible eye care solutions. With a focus on innovation, improved patient care, and expanding healthcare access, the ophthalmology market is set for significant growth in the coming years.

Report Scope and Middle East and Africa Ophthalmology Market Segmentation

Attributes	Middle East and Africa Ophthalmology Market Insights
Segments Covered	By Products: Device, Drugs, and Others By Diseases: Cataract, Refractive Disorders, Glaucoma, Age-Related Macular Degeneration, Inflammatory Diseases, and Others By Comprehensive Eye Examination: Refraction, Visual Acuity Test, Intraocular Pressure, Anterior Segment and Pupillary Examination, Visual Fields Test, Color Vision Test, and Others By End User: Clinics, Hospitals, Home Healthcare, and Others By Distribution Channel: Retail Sales, Direct Tender, and Others
Region Covered	South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and Rest of Middle East and Africa
Key Market Players	Alcon (Switzerland), Bausch + Lomb (Canada), Carl Zeiss Meditec( Germany), Hoya Corporation (Japan), Johnson & Johnson Services, Inc. (U.S.), Essilor International (France), Topcon Corporation(Japan), Glaukos Corporation (U.S.), Haag-Streit Group (Switzerland), Nidek Co., Ltd (U.S.), Staar Surgical (California), Ziemer Ophthalmic Systems Ag (Switzerland), Cooper Companies (U.S.), Lumenis Be Ltd. (Israel), Reichert Inc. (New York), Bayer Ag (Germany), Novartis Ag (Switzerland), Abbvie Inc.(U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Dompé (Italy), Santen Pharmaceutical Co. (Japan), Ltd among others.
Market Opportunities	Rise in the aging population Rise in online retail and e-health platforms Enhanced patient education
Value Added Data Infosets	In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include import export analysis, production capacity overview, production consumption analysis, price trend analysis, climate change scenario, supply chain analysis, value chain analysis, raw material/consumables overview, vendor selection criteria, PESTLE Analysis, Porter Analysis, and regulatory framework.

Middle East and Africa Ophthalmology Market Definition

Ophthalmology is a branch of medicine and surgery that focuses on the diagnosis, treatment, and prevention of eye disorders and diseases. It includes medical and surgical care for conditions affecting the eyes and visual systems, such as cataracts, glaucoma, macular degeneration, and diabetic retinopathy.

Middle East and Africa Ophthalmology Market Definition Dynamics

Drivers

Increasing Prevalence of Eye Diseases

The increasing prevalence of eye conditions, such as cataracts, macular degeneration, and diabetic retinopathy, is a significant driver of the Middle East and Africa ophthalmology market. As the Middle East and Africa population ages, the incidence of these conditions is rise. Cataracts, which lead to blurred vision and blindness, demand an expanding market for surgeries and corrective treatments. Similarly, macular degeneration and diabetic retinopathy are contributing to the need for advanced diagnostic tools and specialized therapies. The growing number of affected individuals ensures sustained demand for eye care services, including surgeries, medications, and innovative diagnostic technologies. This surge in eye diseases directly drives market expansion, as healthcare providers and manufacturers strive to meet the growing need for effective treatments and solutions.

For instance,

In July 2022, according to the article published by NCBI, The prevalence of blindness rises with age, increasing from 0.45% in those aged 50-59 to 11.62% in individuals 80 and older. Females (2.31%) and rural residents (2.14%) experience higher rates. Visual impairment also affects 26.68% of participants, showing similar trends. This growing burden of eye diseases, particularly among the elderly, drives demand for ophthalmic treatments and technologies, boosting the ophthalmology market
In August 2023, according to the article published by WHO, Middle East and Africa, over 2.2 billion people suffer from vision impairment, with nearly 1 billion cases being preventable or untreated. This growing prevalence of vision issues highlights the increasing demand for eye care services, treatments, and corrective solutions. As more people seek medical attention for preventable or unresolved conditions, the rising burden of eye diseases acts as a significant driver for the ophthalmology market

The rising prevalence of age-related eye conditions like cataracts, macular degeneration, and diabetic retinopathy is fueling the Middle East and Africa ophthalmology market. As the population ages, these diseases become more common, increasing the demand for treatments, surgeries, and diagnostic tools. The need for advanced technologies and therapies grows as more people require care. This surge in eye conditions drives market growth, as healthcare providers and manufacturers aim to meet the rising demand for effective solutions.

Focus on Preventative Eye Care

There is a growing emphasis on preventative eye care and early detection of vision-related issues, which is playing a significant role in driving the Middle East and Africa ophthalmology market. As awareness about the importance of eye health increases, more people are seeking routine eye checkups to detect conditions like glaucoma, diabetic retinopathy, and cataracts in their early stages. Early diagnosis allows for timely interventions, reducing the risk of vision loss and improving overall eye health. This proactive approach is not only improving patient outcomes but also fueling demand for ophthalmic services, diagnostic tools, and corrective treatments. The growing focus on preventative care is leading to a surge in investments in eye care technologies, ophthalmic devices, and services, thereby contributing to the market's expansion. This trend strongly acts as a driver for growth in the ophthalmology sector.

For instance,

2022년 10월, National Eye Institute에서 발표한 기사에 따르면, National Eye Health Education Program(NEHEP)은 의료 전문가와 협력하여 조기 발견, 안구 질환 치료 및 시력 재활의 이점에 대한 인식을 증진합니다. 또한 안구 질환 및 시력 상실 위험이 높은 인구를 대상으로 합니다. 예방 치료에 중점을 둠으로써 사람들이 시기적절한 눈 검진 및 치료를 받도록 장려하여 안과 서비스, 진단 도구 및 제품에 대한 수요를 촉진하고, 그로 인해 안과 시장을 활성화합니다.
2024년 10월, 보건 서비스 총국에서 발행한 기사에 따르면, 실명 및 시각 장애 통제를 위한 국가 프로그램(NPCB&VI)은 모든 의료 수준에서 치료 가능한 실명을 식별하고 치료하여 실명 유병률을 줄이는 것을 목표로 합니다. 이 프로그램은 조기 발견과 피할 수 있는 실명에 초점을 맞추어 예방 치료의 중요성을 강조합니다. 이 이니셔티브는 눈 관리 서비스, 진단 도구 및 치료에 대한 수요를 촉진하여 중동 및 아프리카 안과 시장 성장에 크게 기여합니다.

예방적 안과 관리와 조기 발견에 대한 집중이 증가하면서 중동 및 아프리카 안과 시장이 크게 성장하고 있습니다. 안구 건강에 대한 인식이 높아짐에 따라 더 많은 사람들이 녹내장 및 백내장과 같은 질환을 조기에 식별하기 위해 정기적인 안구 검사를 선택하고 있습니다. 조기 발견은 추가적인 시력 상실을 예방하는 효과적인 치료를 가능하게 합니다. 이러한 선제적 접근 방식은 진단 도구, 안과 서비스 및 교정 치료에 대한 수요를 촉진하고 있습니다. 예방적 관리의 중요성이 커지면서 고급 안과 관리 기술에 대한 투자가 촉진되어 안과 시장의 전반적인 성장에 기여하고 지속적인 확장을 보장합니다.

기회

고령화 인구 증가

노령 인구의 증가는 중동 및 아프리카 안과 시장에 상당한 기회를 제공합니다. 노인은 다양한 안구 질환과 질병에 더 취약하기 때문입니다. 백내장, 연령 관련 황반변성(AMD), 당뇨성 망막증, 녹내장과 같은 질환은 노인에게 흔하여 안과 치료와 치료에 대한 상당한 수요가 발생합니다. 결과적으로 의료 시스템과 안과 제공자는 서비스를 확장하고 진단 및 치료 옵션을 개선하며 이 인구통계의 고유한 요구 사항을 충족할 준비가 되었습니다. 이러한 증가하는 환자 기반은 수술적 개입과 고급 약물 요법에서 시력 교정 제품에 이르기까지 다양한 솔루션을 필요로 하며, 안과 시술과 제품에 대한 꾸준하고 증가하는 수요를 보장합니다.

예를 들어,

2023년 3월, National Library of Medicine에 게재된 기사에 따르면, 백내장은 노년기 시력 장애의 주요 원인입니다. 렌즈 불투명화는 허약함, 낙상 위험, 우울증 및 인지 장애를 포함한 여러 노인성 질환과 관련이 있는 것으로 악명 높습니다. 게다가 같은 출처에 따르면, 2020년 50세 이상 환자의 실명의 주요 원인은 백내장이었고, 그 다음으로 녹내장, 교정 미달 굴절 이상, 연령 관련 황반 변성 및 당뇨성 망막증이었습니다.
2022년 8월 미국 안과학회에 발표된 기사에 따르면 AMD는 50세 이상 성인에게 흔히 발견되는 흔한 안구 질환입니다. 게다가 75세 이상 미국인의 절반이 백내장을 앓는다고 합니다.

또한 노령 인구의 눈 건강 요구를 해결하면 안과 분야에서 연구 개발에 대한 추가 투자를 자극할 수 있습니다. 제약 회사와 의료 기기 제조업체는 연령 관련 질환에 맞게 특별히 맞춤화된 혁신적인 솔루션을 만드는 데 주력하고 있으며, 잠재적으로 치료 프로토콜과 환자 치료에 획기적인 진전을 이룰 수 있습니다. 원격 안과 및 고급 영상 기술과 같은 새로운 기술을 통합하면 노인의 눈 건강을 보다 효과적으로 관리할 수 있어 원격으로 상태를 모니터링하고 치료하기가 더 쉬워집니다. 전반적으로 노령 인구는 기존 안과 서비스에 대한 필요성을 증폭시키고 중동 및 아프리카 안과 시장에서 혁신과 성장을 위한 비옥한 토양을 제공합니다.

온라인 소매 및 전자 건강 플랫폼의 증가

온라인 소매 및 e-헬스 플랫폼의 부상은 소비자에게 광범위한 안과 제품 및 서비스에 대한 보다 쉬운 접근성을 제공함으로써 중동 및 아프리카 안과 시장에 상당한 기회를 제공합니다. 전자 상거래의 채택이 증가함에 따라 환자는 처방 안경, 콘택트 렌즈 및 일반 의약품과 같은 품목을 집에서 편안하게 구매할 수 있습니다. 이러한 추세는 특히 젊고 기술에 정통한 소비자와 전통적인 광학 매장에 대한 접근성이 제한된 외딴 지역의 소비자에게 매력적입니다. 가격을 비교하고, 리뷰를 읽고, 온라인에서 더 광범위한 제품에 액세스할 수 있는 기능은 고객 만족도를 높이고 사용을 장려하여 안과 제품 부문의 성장을 촉진합니다.

예를 들어,

2023년 9월, 타임스 오브 인디아의 보도 기사에 따르면, '분홍 눈' 유행으로 인해 안과 약품 판매가 급증했습니다. 8월에는 두 달 연속으로 전년 대비 매출이 30% 가까이 급증했습니다. 전체 시장보다 거의 5배나 성장했습니다. 이 증가는 지난 몇 달 동안 전국적으로 결막염과 눈 합병증이 엄청나게 발생했음을 반영합니다.
2020년 4월, '안경 온라인 구매에 대한 환자의 견해'라는 기사에 따르면, 콘택트렌즈 온라인 구매가 증가하고 있습니다. 호주, 미국 및 영국의 콘택트렌즈 사용자의 10%~20%가 인터넷 구매 가능성을 고려하거나 조사했습니다.

소매 기회 외에도 e-헬스 플랫폼은 환자가 원격으로 안과 전문의와 상담할 수 있는 텔레헬스 서비스를 제공합니다. 일상적인 안과 검사, 후속 조치 및 더 심각한 질환에 대한 분류를 위한 가상 상담은 특히 노인이나 이동에 어려움이 있는 개인의 치료 접근성을 크게 개선할 수 있습니다. 이러한 플랫폼은 환자 참여와 안구 건강 권장 사항 준수를 강화하고 안과 의사가 지리적 경계의 제약 없이 더 광범위한 환자 기반에 도달할 수 있도록 합니다. 또한 안구 건강을 모니터링하거나 만성 질환을 관리하기 위한 모바일 앱과 같은 디지털 건강 도구를 통합하면 원활한 환자 경험을 만들고 사전 예방적 안구 관리를 촉진하여 안과 시장의 성장을 더욱 촉진할 수 있습니다.

제약/도전

안과 수술과 관련된 부작용 및 합병증

안과 치료의 상당한 발전에도 불구하고, 특정 안과 시술, 특히 수술적 개입은 감염, 흉터 또는 시력 장애와 같은 부작용 및 합병증의 위험을 안고 있습니다. 이러한 잠재적 위험은 환자가 특정 치료, 특히 침습적 시술을 포함하는 치료를 받는 것을 막을 수 있습니다. 시력 감소 또는 회복 기간 연장과 같은 부작용에 대한 두려움은 치료를 찾는 데 주저하게 만들어 특정 치료법의 전반적인 채택을 제한할 수 있습니다. 또한 수술로 인한 합병증은 추가 치료를 필요로 할 수 있으며, 이는 의료비를 더욱 증가시키고 진보된 치료에 대한 환자의 신뢰에 영향을 미칩니다. 부정적인 부작용의 가능성으로 인해 치료를 받는 것을 꺼리는 것은 새로운 기술과 치료법의 채택을 늦추어 안과 시장의 전반적인 성장을 제한합니다.

예를 들어,

2024년 10월, 하버드 헬스에서 발표한 기사에 따르면, 현대의 안과 수술은 백내장이나 녹내장과 같은 질환을 치료하는 데 효과적이지만, 타는 듯한 느낌, 자갈 같은 느낌, 가려운 느낌이 특징인 건조증과 같은 합병증을 유발하는 경우가 많습니다. 이러한 부작용은 환자에게 불편하고 낙담하게 만들 수 있으며, 일부는 안과 수술을 주저하거나 피하게 됩니다. 결과적으로 치료로 인한 합병증은 안과 시장 성장을 저해하는 요인으로 작용합니다.
2021년 7월 Medical News Today에 게재된 기사에 따르면, 레이저 눈 수술을 받은 사람의 최대 95%가 건조한 눈을 경험할 수 있고, 20%는 눈부심이나 후광과 같은 시각 장애를 보고했습니다. 또한 50명 중 1명은 시야가 흐릿하거나 "사하라의 모래" 증후군을 겪을 수 있습니다. 이러한 부작용은 환자가 수술을 선택하지 못하게 하고, 레이저 시술을 채택하는 것을 제한하며, 안과 시장 성장을 저해하는 요인으로 작용할 수 있습니다.

안과학의 발전에도 불구하고 일부 수술적 치료는 감염, 흉터 또는 시력 장애와 같은 위험을 수반합니다. 이러한 합병증은 환자가 특정 치료법, 특히 침습적 시술을 선택하지 못하게 할 수 있습니다. 부작용과 추가 치료 비용에 대한 두려움은 환자가 치료를 받으려는 의지를 방해하여 새로운 치료법 채택을 늦출 수 있습니다. 이러한 주저함은 중동 및 아프리카 안과학 시장의 성장을 제한합니다.

농촌 지역에서 전문 안과 진료에 대한 접근성 제한

의료 인프라의 발전에도 불구하고, 농촌과 외딴 지역에서는 전문 안과 치료에 대한 접근성이 제한되어 이 지역에서 안과 시장의 성장 잠재력이 크게 저해되고 있습니다. 많은 농촌 인구는 여전히 훈련된 안과 전문가 부족, 부적절한 시설, 고급 진단 및 치료 기술에 대한 접근성 제한과 같은 어려움에 직면해 있습니다. 그 결과, 이 지역의 개인은 종종 눈 질환에 대한 적시 진단 및 치료를 받는 데 어려움을 겪어 예방 가능한 실명과 시력 장애의 발생률이 높아집니다. 전문 치료의 가용성이 제한되어 고급 안과 치료 서비스 및 제품의 채택이 감소하여 시장 확장이 제한됩니다. 이러한 접근성 장벽은 중동 및 아프리카 안과 시장의 전반적인 성장에 대한 주요 제약으로 계속 작용하고 있습니다.

예를 들어,

NCBI가 발표한 기사에 따르면 2023년 2월 현재 인도의 대규모 농촌 인구는 충족되지 않은 상당한 안과 치료 요구에 직면해 있으며, 대부분의 시설과 전문가는 도시 및 준도시 지역에 집중되어 있습니다. 농촌과 도시 지역 간의 안과 치료 접근성의 격차는 여전히 문제로 남아 있으며, 치료 가용성을 제한합니다. 이러한 불평등한 의료 자원 분배는 농촌 지역에서 필수 서비스에 대한 광범위한 접근을 방해하여 중동 및 아프리카 안과 시장의 성장을 제한합니다.
Research Gate에서 발행한 기사에 따르면 2024년 3월, 원격 지역의 연결성과 숙련된 직원 부족으로 인해 성공적인 안과 캠프가 있더라도 지속적인 안과 진료를 받을 수 없습니다. 이 지역의 환자들은 적절한 인프라가 부족하여 후속 치료나 고급 치료를 받는 데 어려움을 겪습니다. 이러한 의료 서비스 제공의 격차는 안과 진료 프로그램의 도달 범위와 효과를 제한하여 중동 및 아프리카 안과 시장 성장에 제약으로 작용합니다.

의료가 개선되었음에도 불구하고 농촌 지역에서는 전문 안과 진료에 대한 접근성이 여전히 제한적입니다. 안과 진료 전문가, 첨단 기술 및 시설의 부족으로 인해 시기적절한 치료와 진단이 불가능하여 피할 수 있는 실명의 비율이 높아집니다. 이러한 제한된 접근성은 이러한 지역에서 첨단 치료 및 서비스 도입을 제한하여 중동 및 아프리카 안과 시장의 성장을 방해합니다.

중동 및 아프리카 안과 시장 범위

시장은 제품, 질병, 포괄적인 눈 검사, 최종 사용자 및 유통 채널을 기준으로 세분화됩니다. 이러한 세그먼트 간의 성장은 산업의 빈약한 성장 세그먼트를 분석하고 사용자에게 귀중한 시장 개요와 시장 통찰력을 제공하여 핵심 시장 응용 프로그램을 식별하기 위한 전략적 결정을 내리는 데 도움이 됩니다.

제품별

장치
- 수술 장치
  - 백내장 수술 장비
  - 안과용 점탄성 장치
    - 백내장 수술 장치
    - 백내장 수술 레이저
    - IOL 주입기
  - 유리체망막 수술 기구
    - 유리체절제술 기계
    - 유리체망막팩
    - 광응고 레이저
    - 유리체 절제술 프로브
    - 조명 장치
  - 굴절 수술 장치
    - 펨토초 레이저
    - 엑시머 레이저
    - 기타 굴절 수술 레이저
  - 녹내장 수술 장비
    - 녹내장 배액 장치
    - 미세침습성 녹내장 수술 장비
    - 녹내장 레이저 시스템
- 진단 장치
  - 광 간섭 단층촬영(OCT) 스캐너
  - 자동굴절계 및 각막계
  - 안압계
  - 포롭터
  - 망막경
  - 검안경
  - 슬릿램프
  - 경계선/시야 분석기
  - 각막 지형 시스템
  - 안저 카메라
  - 안과 초음파 영상 시스템
    - A- 스캔 이미징 시스템
    - B-스캔 이미징 시스템
    - 파키미터
    - 초음파 생체현미경
  - 렌즈미터
  - 파면수차계
  - 광학 생체측정 시스템
  - 거울현미경
  - 차트 프로젝터
- 안과 수술 액세서리
  - 수술 도구 및 키트
  - 안과용 집게
  - 안과용 주걱
  - 안과용 팁과 핸들
  - 안과용 캐뉼라
  - 안과 가위
  - 기타 수술용 액세서리
- 안과 현미경
약물, 부산물
- 항VEGF 약물
  - 라니비주맙
  - 베바시주맙
- 망막질환 약물
- 항녹내장제
  - 프로스타글란딘 유사체
    - 라타노프로스트
    - 비마토프로스트
    - 트라보프로스트
    - 타플루프로스트
    - 라타노프로스틴
  - 베타 아드레날린 길항제
    - 티몰랄 말레에이트
    - 베탁솔롤
  - 알파 아드레날린 작용제
    - 에피네프린
    - 데피베프린
  - 미오틱스
    - 필로카르핀
    - 에세린
- 건조증약
- 항염제 약물
  - 스테로이드 항염제
  - 비스테로이드성 항염제
- 알레르기성 결막염 약물
- 기타
약물, 약물 유형별
- 브랜드화
- 일반적인
약물, 처방 모드별
- 처방
- 카운터 너머
약물, 투여 경로별
- 뉴스 영화
  - 눈약
  - 눈 솔루션
  - 크림 & 연고
  - 젤라틴
  - 기타
- 지역 안구
  - 유리체내
  - 결막하
  - 후구부
  - 내측
- 주사제
  - 근육내 주사
  - 정맥
  - 기타
- 경구
  - 태블릿
  - 캡슐
  - 기타
- 기타
기타
- 시력 관리 제품
  - 안경
  - 콘택트 렌즈
    - 소프트 콘택트 렌즈
    - 하이브리드 콘택트 렌즈
    - 강성 가스 투과 렌즈
- 기타

질병별로

백내장
굴절 장애
녹내장
연령 관련 황반변성
Inflammatory Diseases
Others

By Comprehensive Eye Examination

Refraction
- Automated Refractometers
- Set of Trial Lenses
- Cycloplegic Drugs
- Trial Frame
- Self-Illuminated/ Mirror Retinoscope
- Jackson Cross Cylinder
Visual Acuity Test
- Snellen's Chart
- Near Vision Charts
Intraocular Pressure
- Tonometers (Goldmann, Tono-Pen, Perkins, Shiotz)
- Others
Anterior Segment and Pupillary Examination
- Slit Lamp Biomicroscope
- Torch Light
Visual Fields Test
- Central 30-2 Full Threshold Humphrey Visual Field Analyzer
- Frequency Doubling Perimeter
- Goldmann Kinetic Perimeter
Color Vision Test
Others

By End User

Clinics
Hospitals
Home Healthcare
Others

By Distribution Channel

Retail sales
- Retail Shops
- Hospital Pharmacy
- Online Pharmacy
Direct Tender
Others

Middle East and Africa Ophthalmology Market Regional Analysis

The market is segmented on the basis of products, diseases, comprehensive eye examination, end user, and distribution channel.

The countries covered in the market are South Africa, Saudi Arabia, U.A.E., Egypt, Israel, and rest of Middle East and Africa.

South Africa is expected to be dominate & fastest growing in the market due to advanced healthcare infrastructure, high healthcare spending, and a large aging population with a growing prevalence of eye diseases. Additionally, significant investments in research, development, and the adoption of cutting-edge technologies drive market leadership in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Middle East and Africa brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Middle East and Africa Ophthalmology Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Middle East and Africa presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Middle East and Africa Ophthalmology Market Leaders Operating in the Market Are:

Alcon (Switzerland)
Bausch + Lomb (Canada)
Carl Zeiss Meditec( Germany)
Hoya Corporation (Japan)
Johnson & Johnson Services, Inc. (U.S.)
Essilor International (France)
Topcon Corporation(Japan)
Glaukos Corporation (U.S.)
Haag-Streit Group (Switzerland)
Nidek Co., Ltd (U.S.)
Staar Surgical (California)
Ziemer Ophthalmic Systems Ag (Switzerland)
Cooper Companies (U.S.)
Lumenis Be Ltd. (Israel)
Reichert Inc. (New York)

Latest Developments in Middle East and Africa Ophthalmology Market

In October 2024, At the AAO 2024 meeting, Alcon showcased its innovations, including the Voyager DSLT for glaucoma treatment, UNIFEYE and UNIPEXY handheld gas delivery systems, and pivotal data for AR-15512, a dry eye treatment. These advancements aimed to improve outcomes and surgical efficiency
In September 2024, EssilorLuxottica and Meta have extended their partnership, entering a long-term agreement to develop multi-generational smart eyewear products. Building on the success of Ray-Ban Meta glasses, the companies aim to shape the future of wearable technology together
In OCTOBER 2024, Bausch + Lomb presented new scientific data and educational events at the 2024 AAO meeting in Chicago. Highlights included studies on the enVista Envy IOL, TENEO Excimer Laser, VYZULTA, and presentations on Blink Nutritears, MIEBO, and Xiidra
In April 2024, AbbVie has completed its acquisition of Cerevel Therapeutics, enhancing its neuroscience portfolio. The acquisition includes Cerevel’s promising clinical-stage assets like Emraclidine for schizophrenia and Tavapadon for Parkinson's disease, strengthening AbbVie’s position in neurology and psychiatry
In September, 2023, Novartis completed the divestment of its 'front of eye' ophthalmology assets to Bausch + Lomb for up to USD 2.5 billion, including USD 1.75 billion in upfront cash and potential milestone payments. The deal included Xiidra, SAF312, AcuStream, and OJL332. Novartis advanced its strategy to focus on prioritized therapeutic areas for future growth

SKU-69594

세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요

Click on image to enlarge

대화형 데이터 분석 대시보드
높은 성장 잠재력 기회를 위한 회사 분석 대시보드
사용자 정의 및 질의를 위한 리서치 분석가 액세스
대화형 대시보드를 통한 경쟁자 분석
최신 뉴스, 업데이트 및 추세 분석
포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용

데모 요청

표 목록

TABLE 1 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 2 MIDDLE EAST AND AFRICA DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 3 MIDDLE EAST AND AFRICA SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 4 MIDDLE EAST AND AFRICA OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 5 MIDDLE EAST AND AFRICA VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 6 MIDDLE EAST AND AFRICA REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2032 (USD MILLION)

TABLE 7 MIDDLE EAST AND AFRICA GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 8 MIDDLE EAST AND AFRICA DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 9 MIDDLE EAST AND AFRICA OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 10 MIDDLE EAST AND AFRICA OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 11 MIDDLE EAST AND AFRICA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2032 (USD MILLION)

TABLE 12 MIDDLE EAST AND AFRICA ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2032 (USD MILLION)

TABLE 13 MIDDLE EAST AND AFRICA ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 14 MIDDLE EAST AND AFRICA PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 15 MIDDLE EAST AND AFRICA BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 16 MIDDLE EAST AND AFRICA ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2032 (USD MILLION)

TABLE 17 MIDDLE EAST AND AFRICA MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2032 (USD MILLION)

TABLE 18 MIDDLE EAST AND AFRICA ANTI INFLAMMATION DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2021-2032 (USD MILLION)

TABLE 19 MIDDLE EAST AND AFRICA DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 20 MIDDLE EAST AND AFRICA DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 21 MIDDLE EAST AND AFRICA DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 22 MIDDLE EAST AND AFRICA TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 23 MIDDLE EAST AND AFRICA LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 24 MIDDLE EAST AND AFRICA INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 25 MIDDLE EAST AND AFRICA ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 26 MIDDLE EAST AND AFRICA OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 27 MIDDLE EAST AND AFRICA VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 28 MIDDLE EAST AND AFRICA CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 29 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 30 MIDDLE EAST AND AFRICA CATARACT IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 31 MIDDLE EAST AND AFRICA REFRACTIVE DISORDERS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 32 MIDDLE EAST AND AFRICA GLAUCOMA IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 33 MIDDLE EAST AND AFRICA AGE-RELATED MACULAR DEGENERATION IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 34 MIDDLE EAST AND AFRICA INFLAMMATORY DISEASES IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 35 MIDDLE EAST AND AFRICA OTHERS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 36 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 37 MIDDLE EAST AND AFRICA REFRACTION IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 38 MIDDLE EAST AND AFRICA REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 39 MIDDLE EAST AND AFRICA VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 40 MIDDLE EAST AND AFRICA VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 41 MIDDLE EAST AND AFRICA INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 42 MIDDLE EAST AND AFRICA INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 43 MIDDLE EAST AND AFRICA ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 44 MIDDLE EAST AND AFRICA ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 45 MIDDLE EAST AND AFRICA VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 46 MIDDLE EAST AND AFRICA VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 47 MIDDLE EAST AND AFRICA COLOR VISION TEST IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 48 MIDDLE EAST AND AFRICA OTHERS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 49 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 50 MIDDLE EAST AND AFRICA CLINICS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 51 MIDDLE EAST AND AFRICA HOSPITALS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 52 MIDDLE EAST AND AFRICA HOME HEALTHCARE IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 53 MIDDLE EAST AND AFRICA OTHERS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 54 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 55 MIDDLE EAST AND AFRICA RETAIL SALES IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 56 MIDDLE EAST AND AFRICA RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 57 MIDDLE EAST AND AFRICA DIRECT TENDER IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 58 MIDDLE EAST AND AFRICA OTHERS IN OPHTHALMOLOGY MARKET, BY REGION, 2018-2032 (USD MILLION)

TABLE 59 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET, BY COUNTRY, 2018-2032 (USD MILLION)

TABLE 60 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 61 MIDDLE EAST AND AFRICA DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 62 MIDDLE EAST AND AFRICA SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 63 MIDDLE EAST AND AFRICA OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 64 MIDDLE EAST AND AFRICA VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 65 MIDDLE EAST AND AFRICA REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 66 MIDDLE EAST AND AFRICA GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 67 MIDDLE EAST AND AFRICA DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 68 MIDDLE EAST AND AFRICA OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 69 MIDDLE EAST AND AFRICA OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 70 MIDDLE EAST AND AFRICA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 71 MIDDLE EAST AND AFRICA ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 72 MIDDLE EAST AND AFRICA ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 73 MIDDLE EAST AND AFRICA PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 74 MIDDLE EAST AND AFRICA BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 75 MIDDLE EAST AND AFRICA ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 76 MIDDLE EAST AND AFRICA MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 77 MIDDLE EAST AND AFRICA ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 78 MIDDLE EAST AND AFRICA OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 79 MIDDLE EAST AND AFRICA VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 80 MIDDLE EAST AND AFRICA CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 81 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 82 MIDDLE EAST AND AFRICA DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 83 MIDDLE EAST AND AFRICA DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 84 MIDDLE EAST AND AFRICA DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 85 MIDDLE EAST AND AFRICA TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 86 MIDDLE EAST AND AFRICA LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 87 MIDDLE EAST AND AFRICA INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 88 MIDDLE EAST AND AFRICA ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 89 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 90 MIDDLE EAST AND AFRICA REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 91 MIDDLE EAST AND AFRICA VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 92 MIDDLE EAST AND AFRICA INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 93 MIDDLE EAST AND AFRICA ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 94 MIDDLE EAST AND AFRICA VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 95 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 96 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 97 MIDDLE EAST AND AFRICA RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 98 SOUTH AFRICA OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 99 SOUTH AFRICA DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 100 SOUTH AFRICA SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 101 SOUTH AFRICA OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 102 SOUTH AFRICA VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 103 SOUTH AFRICA REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 104 SOUTH AFRICA GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 105 SOUTH AFRICA DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 106 SOUTH AFRICA OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 107 SOUTH AFRICA OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 108 SOUTH AFRICA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 109 SOUTH AFRICA ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 110 SOUTH AFRICA ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 111 SOUTH AFRICA PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 112 SOUTH AFRICA BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 113 SOUTH AFRICA ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 114 SOUTH AFRICA MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 115 SOUTH AFRICA ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 116 SOUTH AFRICA OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 117 SOUTH AFRICA VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 118 SOUTH AFRICA CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 119 SOUTH AFRICA OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 120 SOUTH AFRICA DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 121 SOUTH AFRICA DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 122 SOUTH AFRICA DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 123 SOUTH AFRICA TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 124 SOUTH AFRICA LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 125 SOUTH AFRICA INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 126 SOUTH AFRICA ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 127 SOUTH AFRICA OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 128 SOUTH AFRICA REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 129 SOUTH AFRICA VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 130 SOUTH AFRICA INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 131 SOUTH AFRICA ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 132 SOUTH AFRICA VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 133 SOUTH AFRICA OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 134 SOUTH AFRICA OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 135 SOUTH AFRICA RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 136 SAUDI ARABIA OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 137 SAUDI ARABIA DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 138 SAUDI ARABIA SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 139 SAUDI ARABIA OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 140 SAUDI ARABIA VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 141 SAUDI ARABIA REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 142 SAUDI ARABIA GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 143 SAUDI ARABIA DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 144 SAUDI ARABIA OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 145 SAUDI ARABIA OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 146 SAUDI ARABIA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 147 SAUDI ARABIA ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 148 SAUDI ARABIA ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 149 SAUDI ARABIA PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 150 SAUDI ARABIA BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 151 SAUDI ARABIA ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 152 SAUDI ARABIA MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 153 SAUDI ARABIA ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 154 SAUDI ARABIA OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 155 SAUDI ARABIA VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 156 SAUDI ARABIA CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 157 SAUDI ARABIA OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 158 SAUDI ARABIA DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 159 SAUDI ARABIA DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 160 SAUDI ARABIA DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 161 SAUDI ARABIA TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 162 SAUDI ARABIA LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 163 SAUDI ARABIA INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 164 SAUDI ARABIA ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 165 SAUDI ARABIA OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 166 SAUDI ARABIA REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 167 SAUDI ARABIA VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 168 SAUDI ARABIA INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 169 SAUDI ARABIA ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 170 SAUDI ARABIA VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 171 SAUDI ARABIA OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 172 SAUDI ARABIA OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 173 SAUDI ARABIA RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 174 U.A.E OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 175 U.A.E DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 176 U.A.E SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 177 U.A.E OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 178 U.A.E VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 179 U.A.E REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 180 U.A.E GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 181 U.A.E DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 182 U.A.E OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 183 U.A.E OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 184 U.A.E DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 185 U.A.E ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 186 U.A.E ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 187 U.A.E PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 188 U.A.E BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 189 U.A.E ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 190 U.A.E MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 191 U.A.E ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 192 U.A.E OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 193 U.A.E VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 194 U.A.E CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 195 U.A.E OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 196 U.A.E DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 197 U.A.E DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 198 U.A.E DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 199 U.A.E TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 200 U.A.E LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 201 U.A.E INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 202 U.A.E ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 203 U.A.E OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 204 U.A.E REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 205 U.A.E VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 206 U.A.E INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 207 U.A.E ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 208 U.A.E VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 209 U.A.E OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 210 U.A.E OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 211 U.A.E RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 212 EGYPT OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 213 EGYPT DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 214 EGYPT SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 215 EGYPT OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 216 EGYPT VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 217 EGYPT REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 218 EGYPT GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 219 EGYPT DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 220 EGYPT OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 221 EGYPT OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 222 EGYPT DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 223 EGYPT ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 224 EGYPT ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 225 EGYPT PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 226 EGYPT BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 227 EGYPT ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 228 EGYPT MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 229 EGYPT ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 230 EGYPT OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 231 EGYPT VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 232 EGYPT CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 233 EGYPT OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 234 EGYPT DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 235 EGYPT DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 236 EGYPT DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 237 EGYPT TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 238 EGYPT LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 239 EGYPT INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 240 EGYPT ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 241 EGYPT OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 242 EGYPT REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 243 EGYPT VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 244 EGYPT INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 245 EGYPT ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 246 EGYPT VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 247 EGYPT OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 248 EGYPT OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 249 EGYPT RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 250 ISRAEL OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 251 ISRAEL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 252 ISRAEL SURGICAL DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCT, 2018-2032 (USD MILLION)

TABLE 253 ISRAEL OPHTHALMIC VISCOELASTIC DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 254 ISRAEL VITREORETINAL SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 255 ISRAEL REFRACTIVE SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 256 ISRAEL GLAUCOMA SURGICAL DEVICES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 257 ISRAEL DIAGNOSTIC DEVICE IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 258 ISRAEL OPHTHALMIC ULTRASOUND IMAGING SYSTEMS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 259 ISRAEL OPHTHALMIC SURGICAL ACCESSORIES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 260 ISRAEL DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 261 ISRAEL ANTI-VEGF DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 262 ISRAEL ANTI-GLAUCOMA DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 263 ISRAEL PROSTAGLANDIN ANALOGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 264 ISRAEL BETA ADRENERGIC ANTAGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 265 ISRAEL ALPHA ADRENERGIC AGONISTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 266 ISRAEL MIOTICS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 267 ISRAEL ANTI-INFLAMMATORY DRUGS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 268 ISRAEL OTHERS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 269 ISRAEL VISION CARE PRODUCTS IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 270 ISRAEL CONTACT LENSES IN OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

TABLE 271 ISRAEL OPHTHALMOLOGY MARKET, BY DISEASES, 2018-2032 (USD MILLION)

TABLE 272 ISRAEL DRUGS IN OPHTHALMOLOGY MARKET, BY DRUG TYPE, 2018-2032 (USD MILLION)

TABLE 273 ISRAEL DRUGS IN OPHTHALMOLOGY MARKET, BY PRESCRIPTION MODE, 2018-2032 (USD MILLION)

TABLE 274 ISRAEL DRUGS IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 275 ISRAEL TOPICAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 276 ISRAEL LOCAL OCULAR IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 277 ISRAEL INJECTABLES IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 278 ISRAEL ORAL IN OPHTHALMOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2018-2032 (USD MILLION)

TABLE 279 ISRAEL OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 280 ISRAEL REFRACTION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 281 ISRAEL VISUAL ACUITY TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 282 ISRAEL INTRAOCULAR PRESSURE IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 283 ISRAEL ANTERIOR SEGMENT AND PUPILLARY EXAMINATION IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 284 ISRAEL VISUAL FIELDS TEST IN OPHTHALMOLOGY MARKET, BY COMPREHENSIVE EYE EXAMINATION, 2018-2032 (USD MILLION)

TABLE 285 ISRAEL OPHTHALMOLOGY MARKET, BY END USER, 2018-2032 (USD MILLION)

TABLE 286 ISRAEL OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 287 ISRAEL RETAIL SALES IN OPHTHALMOLOGY MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

TABLE 288 REST OF MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET, BY PRODUCTS, 2018-2032 (USD MILLION)

그림 목록

FIGURE 1 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: SEGMENTATION

FIGURE 2 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: DATA TRIANGULATION

FIGURE 3 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: DROC ANALYSIS

FIGURE 4 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 8 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: DBMR MARKET POSITION GRID

FIGURE 9 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: SEGMENTATION

FIGURE 11 THREE SEGMENTS COMPRISE THE MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET, BY PRODUCTS

FIGURE 12 EXECUTIVE SUMMARY

FIGURE 13 STRATEGIC DECISIONS

FIGURE 14 RISING INCIDENCE OF EYE DISORDERS IS DRIVING THE GROWTH OF THE MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET FROM 2025 TO 2032

FIGURE 15 THE PRODUCTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET IN 2025 AND 2032

FIGURE 16 DROC ANALYSIS

FIGURE 17 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: BY PRODUCTS, 2024

FIGURE 18 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: BY PRODUCTS, 2025-2032 (USD MILLION)

FIGURE 19 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: BY PRODUCTS, CAGR (2025-2032)

FIGURE 20 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: BY PRODUCTS, LIFELINE CURVE

FIGURE 21 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: BY DISEASES, 2024

FIGURE 22 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: BY DISEASES, 2025-2032 (USD MILLION)

FIGURE 23 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: BY DISEASES, CAGR (2025-2032)

FIGURE 24 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: BY DISEASES, LIFELINE CURVE

FIGURE 25 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: BY COMPREHENSIVE EYE EXAMINATION, 2024

FIGURE 26 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: BY COMPREHENSIVE EYE EXAMINATION, 2025-2032 (USD MILLION)

FIGURE 27 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: BY COMPREHENSIVE EYE EXAMINATION, CAGR (2025-2032)

FIGURE 28 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: BY COMPREHENSIVE EYE EXAMINATION, LIFELINE CURVE

FIGURE 29 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: BY END USER, 2024

FIGURE 30 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: BY END USER, 2025-2032 (USD MILLION)

FIGURE 31 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: BY END USER, CAGR (2025-2032)

FIGURE 32 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: BY END USER, LIFELINE CURVE

FIGURE 33 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: BY DISTRIBUTION CHANNEL ,2024

FIGURE 34 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)

FIGURE 35 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2025-2032)

FIGURE 36 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 37 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET SNAPSHOT

FIGURE 38 MIDDLE EAST AND AFRICA OPHTHALMOLOGY MARKET: COMPANY SHARE 2024 (%)

자세한 정보 보기

연구 방법론

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.

DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.

사용자 정의 가능

Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.

자주 묻는 질문

What are the growth drivers of the Middle East and Africa Ophthalmology Market?

Rise in traumatic injuries and Rising prevalence of ophthalmic disorders & ocular pains are the growth drivers of the Middle East and Africa Ophthalmology Market.

What are the factors on which the Middle East and Africa Ophthalmology Market research is based on?

The products, disease, prescription mode, drug type, route of administration, end user, and distribution channel are the factors on which the Middle East and Africa Ophthalmology Market research is based.

Which are the major companies in the Middle East and Africa Ophthalmology Market?

The major companies in the Middle East and Africa Ophthalmology Market are Alcon, Regeneron Pharmaceuticals Inc., Johnson & Johnson, Inc., Novartis AG, Bausch & Lomb Incorporated, HOYA Corporation., The Cooper Companies Inc., Santen Pharmaceutical Co., Ltd., F. Hoffmann-La Roche Ltd, Carl Zeiss Meditec AG, AbbVie Inc., EssilorLuxottica, NIDEK CO., LTD., TOPCON CORPORATION, Glaukos Corporation., STAAR SURGICAL, Metall Zug AG, Sun Pharmaceutical Industries Ltd., Pfizer Inc., and Ziemer Ophthalmic Systems AG.